| Long-term effects of angiotensin II receptor blockade with valsartan on carotid arterial stiffness and hemodynamic alterations in patients with essential hypertension. | |
| | |
MedLine Citation:
|
PMID: 18633763 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Increased arterial stiffness and intima media thickness (IMT) in the common carotid artery (CCA) are related to cardiovascular risk in essential hypertension. Angiotensin II plays an important role in structural and functional changes in the vasculature. In this study, we evaluated the long-term effect of the angiotensin II receptor blocker, valsartan, on IMT, arterial stiffness, and hemodynamics in the CCA in patients with essential hypertension. A prospective 24 month study of treatment with valsartan (80-160 mg/day) was performed in 24 hypertensive patients. An ultrasound of the CCA was carried out to determine IMT, the cross-sectional distensibility coefficient (CSDC), the carotid arterial stiffness index beta, and diastolic flow velocity to systolic flow velocity ratio (Vd/Vs). Treatment with valsartan for 24 months reduced systolic and diastolic blood pressure significantly. Compared to baseline, the decrease in pulse pressure was greater after 24 months treatment than after 12 months treatment. Valsartan did not influence IMT; however, after 24 months, it caused a significant increase in CSDC and a decrease in stiffness index beta compared to baseline. These changes were not observed after 12 months of treatment. In addition, Vd/Vs, a sensitive marker of relative diastolic blood flow, increased after 24 months' treatment with valsartan. These results suggest that long-term treatment with valsartan improves vascular wall function and hemodynamics in patients with essential hypertension. |
| | |
Authors:
|
Takafumi Okura; Sanae Watanabe; Mie Kurata; Mitsuko Koresawa; Jun Irita; Daijiro Enomoto; Masanori Jotoku; Ken-Ichi Miyoshi; Tomikazu Fukuoka; Jitsuo Higaki |
Related Documents
:
|
10411373 - Masoprocol lowers blood pressure in rats with fructose-induced hypertension. 8595083 - Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in p... 11540693 - Cardiovascular adaptations to parabolic flight in rats: a radio-telemetry feasibility ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical and experimental hypertension (New York, N.Y. : 1993) Volume: 30 ISSN: 1525-6006 ISO Abbreviation: Clin. Exp. Hypertens. Publication Date: 2008 Jul |
Date Detail:
|
Created Date: 2008-07-17 Completed Date: 2008-09-19 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9305929 Medline TA: Clin Exp Hypertens Country: United States |
Other Details:
|
Languages: eng Pagination: 415-22 Citation Subset: IM |
Affiliation:
|
Department of Integrated Medicine and Informatics, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, Japan. okura@m.ehime-u.ac.jp |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Angiotensin II Type 1 Receptor Blockers / pharmacology*, therapeutic use Blood Flow Velocity / drug effects Carotid Artery, Common / drug effects*, physiopathology, ultrasonography Elasticity / drug effects Female Humans Hypertension / drug therapy, physiopathology*, ultrasonography Male Prospective Studies Tetrazoles / pharmacology*, therapeutic use Time Factors Treatment Outcome Tunica Media / drug effects, pathology, ultrasonography Valine / analogs & derivatives*, pharmacology, therapeutic use Vascular Resistance / drug effects* |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin II Type 1 Receptor Blockers; 0/Tetrazoles; 137862-53-4/valsartan; 7004-03-7/Valine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The importance of integrated risk management when treating patients with hypertension: benefits of a...
Next Document: The effect of enalapril and telmisartan on clinical and biochemical indices of sympathetic activity ...